The expression of CD44 could be associated with tumor subtypes and be a biomarker of cancer stem cells [12], nonetheless, it is impossible to target CD44 directly for cancer therapy since CD44 is also required for the function of stem cells as well as immune cells [13]. The gene discussed is CD44; the disease is cancer.